Suleman, Sufyan
Ängquist, Lars
Linneberg, Allan
Hansen, Torben
Grarup, Niels
Funding for this research was provided by:
Danmarks Frie Forskningsfond (1030-00280B, 1030-00280B)
Novo Nordisk Fonden (NNF18CC0034900, NNF18CC0034900, NNF18CC0034900, NNF18CC0034900)
Article History
Received: 20 October 2024
Accepted: 11 April 2025
First Online: 6 May 2025
Declarations
:
: N.G is currently employed at Novo Nordisk A/S. T.H owns stocks in Novo Nordisk A/S. Remaining authors declared no competing interests.